Anika Therapeutics, Inc. (ANIK) Ownership
ANIK ownership summary
as of October 18, 2026- Institutions
- 93.7% of shares outstanding
- Insiders
- 6.40% of shares outstanding
- Shares outstanding
- 13.4M
- Float
- 11.3M shares available to trade
- Short interest
- 3.60% 367K shares short
- Days to cover
- 4.53 short interest down 3.7% vs prior month
- Institutions 93.73%
- Insiders 6.40%
ANIK top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | BlackRock Inc | 10.83% | 1.4M | $29.0M | −145,222 (−9.1%) | June 30, 2026 |
| 2 | Caligan Partners LP | 10.72% | 1.4M | $28.7M | — | June 30, 2026 |
| 3 | Morgan Stanley - Brokerage Accounts | 4.59% | 614K | $12.3M | −257,746 (−29.6%) | June 30, 2026 |
| 4 | Acadian Asset Management LLC | 4.53% | 607K | $12.1M | — | June 30, 2026 |
| 5 | Vanguard Capital Management, LLC | 4.27% | 572K | $11.4M | −33,664 (−5.6%) | June 30, 2026 |
| 6 | AQR Capital Management LLC | 4.18% | 560K | $11.2M | +287,577 (+105.6%) | June 30, 2026 |
| 7 | BOOTHBAY FUND MANAGEMENT, LLC | 3.96% | 530K | $10.6M | +137 (+0.0%) | June 30, 2026 |
| 8 | Renaissance Technologies Corp | 3.60% | 481K | $9.6M | −20,800 (−4.1%) | June 30, 2026 |
| 9 | Dimensional Fund Advisors, Inc. | 3.37% | 451K | $9.0M | −7,752 (−1.7%) | June 30, 2026 |
| 10 | Capital Management Corp | 3.35% | 448K | $9.0M | +753 (+0.2%) | June 30, 2026 |
| 11 | Deutsche Bank AG | 2.64% | 354K | $7.1M | +378 (+0.1%) | June 30, 2026 |
| 12 | Geode Capital Management, LLC | 2.48% | 332K | $6.6M | +1,526 (+0.5%) | June 30, 2026 |
| 13 | State Street Corp | 2.33% | 312K | $6.2M | −34,196 (−9.9%) | June 30, 2026 |
| 14 | Two Sigma Investments LLC | 1.89% | 253K | $5.1M | +16,844 (+7.1%) | June 30, 2026 |
| 15 | D. E. Shaw & Co LP | 1.83% | 245K | $4.9M | +15,270 (+6.6%) | June 30, 2026 |
| 16 | The Goldman Sachs Group Inc | 1.78% | 238K | $4.7M | +19,844 (+9.1%) | June 30, 2026 |
| 17 | Jacobs Levy Equity Management, Inc. | 1.63% | 218K | $4.3M | −48,097 (−18.1%) | June 30, 2026 |
| 18 | Nuveen, LLC | 1.17% | 157K | $3.1M | +35,821 (+29.7%) | June 30, 2026 |
| 19 | Quantinno Capital Management LP | 1.16% | 155K | $3.1M | +29,431 (+23.4%) | June 30, 2026 |
| 20 | UBS Group AG | 1.09% | 146K | $2.9M | +12,742 (+9.6%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 11 holders added 420K shares and 7 cut 547K.
ANIK top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 2.97% | 398K | $7.9M | — | August 31, 2026 |
| 2 | iShares Russell 2000 ETF | 2.25% | 301K | $6.0M | −3,456 (−1.1%) | September 30, 2026 |
| 3 | CREF Total Global Stock Account R3 | 0.95% | 127K | $2.5M | −7,125 (−5.3%) | August 31, 2026 |
| 4 | Fidelity Small Cap Index | 0.92% | 124K | $2.5M | +889 (+0.7%) | July 31, 2026 |
| 5 | BSF Systematic US Eq Abs Ret A2 USD | 0.83% | 110K | $2.2M | +13,750 (+14.2%) | December 31, 2025 |
| 6 | Fidelity Small-Mid Multifactor ETF | 0.79% | 106K | $2.1M | — | September 30, 2026 |
| 7 | iShares Russell 2000 Value ETF | 0.79% | 105K | $2.1M | +160 (+0.2%) | September 30, 2026 |
| 8 | DFA US Small Cap Value I | 0.76% | 102K | $2.0M | +14,087 (+16.1%) | August 31, 2026 |
| 9 | Schwab US Small-Cap ETF™ | 0.52% | 69K | $1.4M | +45 (+0.1%) | September 30, 2026 |
| 10 | Vanguard Russell 2000 ETF | 0.50% | 67K | $1.3M | +798 (+1.2%) | September 30, 2026 |
| 11 | Fidelity Extended Market Index | 0.49% | 66K | $1.3M | −354 (−0.5%) | August 31, 2026 |
| 12 | DFA US Small Cap I | 0.46% | 61K | $1.2M | — | August 31, 2026 |
| 13 | Xtrackers S&P Global Infra Swap ETF 1C | 0.38% | 51K | $1.0M | — | December 31, 2025 |
| 14 | DFA US Micro Cap I | 0.37% | 49K | $984,714 | — | August 31, 2026 |
| 15 | Dimensional US Small Cap Value ETF | 0.35% | 47K | $947,192 | — | September 24, 2026 |
| 16 | MFS Blended Research Small Cap Eq R6 | 0.34% | 46K | $916,622 | −493 (−1.1%) | August 31, 2026 |
| 17 | Dimensional US Small Cap ETF | 0.31% | 41K | $822,816 | — | September 30, 2026 |
| 18 | iShares Micro-Cap ETF | 0.27% | 36K | $720,778 | −249 (−0.7%) | September 30, 2026 |
| 19 | Multi-Manager Small Cap Eq Strat Inst | 0.22% | 29K | $580,619 | — | September 30, 2026 |
| 20 | Schwab Small Cap Index | 0.22% | 29K | $576,423 | +1,823 (+6.7%) | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
ANIK insider transactions
latest 1| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2022-05-11 | David Colleran | Buy | $21.37 | 1,500 | $32,055 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
ANIK shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns ANIK
Institutional investors own 93.7% of Anika Therapeutics's shares and insiders 6.40%. The largest holder is BlackRock Inc with 10.83% of the shares (1.4M), as of June 30, 2026. Among the top 20 institutions, 11 added shares and 7 reduced their stake in the latest filings. Short interest is 3.60% of the float, or 4.53 days of average trading volume. The share count fell 4.0% since 2014.
Related: ANIK analyst forecast, ANIK key metrics. See the ANIK stock overview for the latest quote and news.
ANIK ownership FAQ
Who owns the most Anika Therapeutics stock?
The largest shareholders of Anika Therapeutics are BlackRock Inc (10.83%), Caligan Partners LP (10.72%), Morgan Stanley - Brokerage Accounts (4.59%), Acadian Asset Management LLC (4.53%), Vanguard Capital Management, LLC (4.27%).
What percentage of Anika Therapeutics is owned by institutions?
Institutions hold 93.7% of Anika Therapeutics's shares outstanding; insiders hold 6.40%.
Which funds own Anika Therapeutics?
The largest fund holders of Anika Therapeutics are Vanguard MStar Total Stk Mkt Idx Invest (2.97%), iShares Russell 2000 ETF (2.25%), CREF Total Global Stock Account R3 (0.95%), Fidelity Small Cap Index (0.92%), BSF Systematic US Eq Abs Ret A2 USD (0.83%).
What is Anika Therapeutics's short interest?
367K shares of Anika Therapeutics were sold short, 3.60% of the float; at the average daily volume it would take 4.53 days to cover.
Are insiders buying or selling Anika Therapeutics?
Of the latest 1 reported insider transactions in Anika Therapeutics (since May 11, 2022), 1 were purchases and 0 were sales.
How many shares of Anika Therapeutics are outstanding?
Anika Therapeutics has 13.4M shares outstanding, of which 11.3M are in the public float.